News Conference News EuroPCR 2025 Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI Michael O'Riordan May 23, 2025
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News TCT 2020 Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II Todd Neale October 15, 2020
News Conference News The Structural Heart Disease Summit 2018 SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications Michael O'Riordan June 23, 2018
News Conference News ISET 2018 Next-Generation Large-Bore Closure Devices Arrive Caitlin E. Cox February 05, 2018
News Conference News ACC 2017 Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery Michael O'Riordan March 19, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Conference News TCT 2016 Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint Shelley Wood November 01, 2016